Govt ramps up Remdesivir production

New Delhi, May 17

The Union Chemical Ministry on Monday said country’s Remdesivir production capacity has increased from 38 lakh vials per month to nearly 119 lakh vials per month.

“With the efforts of the Centre and the manufacturing companies, the production capacity of the licensed manufacturers has increased unprecedentedly,” the Department of Pharmaceuticals of the Ministry said.

Remdesivir is a patented drug, manufactured in India under voluntary licences granted by Gilead Life Sciences USA, the patent holder, to seven Indian pharmaceutical companies (Cipla, Dr Reddy’s Lab, Hetero, Jubilant Pharma, Mylan, Syngene and Zydus Cadila).

To augment the domestic production capacity, all seven domestic licensed manufacturers of Remdesivir were asked to ramp up production quickly. — TNS